I agree that this site is using cookies. You can find further informations here.
X
Paubel, P.
100  results:
Search for persons X
?
1

OP19 Monoclonal Antibodies in Oncology: A Comparative Analy..:

Moracchini, M. ; Tano, M. ; Siorat, V....
Value in Health.  26 (2023)  12 - p. S445 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Management of perioperative iron deficiency anemia as part ..:

Lasocki, Sigismond ; Delahaye, D. ; Fuks, D....
Transfusion.  63 (2023)  9 - p. 1692-1700 , 2023
Link: https://doi.org/10.1111/..
 
?
3

HPR153 Market Access Strategies for Advanced Therapy Drugs:..:

Claver Sicilia, C. ; Paubel, P. ; Fusier, I..
Value in Health.  26 (2023)  12 - p. S280 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EE124 Analysis of the Use of the Haute Autorité De Santé (H..:

Moutier, H. ; Paubel, P. ; Fusier, I..
Value in Health.  26 (2023)  12 - p. S74 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Prices of Orphan Drugs in Four Western European Countries B..:

Dane, Aniek ; Klein Gebbink, Anne-Sophie ; Brugma, Jan-Dietert...
Applied Health Economics and Health Policy.  21 (2023)  6 - p. 905-914 , 2023
Link: https://doi.org/10.1007/..
 
?
6

HTA143 Drug Market Access Delays in France: What Role May C..:

Cartolano, P. ; Tano, M. ; Siorat, V....
Value in Health.  26 (2023)  12 - p. S346 , 2023
Link: https://doi.org/10.1016/..
 
?
7

EE580 New Anti-CGRP in France: Estimated Financial Impact o..:

Cartolano, P. ; Tano, M. ; Siorat, V....
Value in Health.  26 (2023)  12 - p. S164-S165 , 2023
Link: https://doi.org/10.1016/..
 
?
8

OP25 Developments in Anticancer Drugs Preparation Activity ..:

Moracchini, M. ; Tano, M. ; Siorat, V....
Value in Health.  26 (2023)  12 - p. S446 , 2023
Link: https://doi.org/10.1016/..
 
?
9

OP8 A New Complement Inhibitor: Impact of Ravulizumab on Ec..:

Romero, C. ; Fusier, I. ; Siorat, V...
Value in Health.  26 (2023)  12 - p. S443 , 2023
Link: https://doi.org/10.1016/..
 
?
10

HPR194 New Framework for Early Access to Drugs in France: F..:

Denoual, C. ; Siorat, V. ; Fusier, I...
Value in Health.  26 (2023)  12 - p. S287 , 2023
Link: https://doi.org/10.1016/..
 
?
11

HPR14 Identifying the Key Drivers of Biosimilar Uptake in P..:

Boudjenah, Y ; Tano, M ; Siorat, V...
Value in Health.  25 (2022)  12 - p. S234 , 2022
Link: https://doi.org/10.1016/..
 
?
12

EE616 Management of Chronic Lymphocytic Leukemia: What Impa..:

Berrebi, D ; Siorat, V ; Paubel, P..
Value in Health.  25 (2022)  12 - p. S177 , 2022
Link: https://doi.org/10.1016/..
 
?
13

HPR28 Assessment of the French National Experimentation for..:

Tano, M ; Degrassat Theas, A ; Ribault, M.
Value in Health.  25 (2022)  7 - p. S471-S472 , 2022
Link: https://doi.org/10.1016/..
 
?
14

HPR208 Analysis of Substitution Procurement Agreements and ..:

Guichard, L ; Delion, M ; Monnier, M...
Value in Health.  25 (2022)  12 - p. S271 , 2022
Link: https://doi.org/10.1016/..
 
?
15

HPR154 Appropriate Use of Anti-PD(L)1 in Paris Public Hospi..:

Grangé, L ; Siorat, V ; Fusier, I..
Value in Health.  25 (2022)  12 - p. S260 , 2022
Link: https://doi.org/10.1016/..
 
1-15